Why the study?
Does the etiology of heart failure (ischemic vs nonischemic) require different pharmacologic treatment strategies?
Does the etiology of heart failure (ischemic vs nonischemic) require different pharmacologic treatment strategies?
Ischemic and nonischemic heart failure share similar pathophysiology following myocardial injury and should be treated with the same universal guideline-directed pharmacologic strategy.
No takes yet. Share an insight, caveat, or question.
Reinforces universal GDMT for HF irrespective of etiology; confirms prior ACC/AHA, ESC guidelines and beta-blocker trials.
Abraham et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: